Out Today ANDREW A. DAHL, CEO AND WILLIAM P. PFUND, VP R&D
OF ZIVO BIOSCIENCE, INC.
SPEAKERS AT THE 2020 ALGAE BIOMASS ORGANIZATION ("ABO")
The Algae Biomass Organization (“ABO”) 2020 Summit is hosting its special series of Industry Spotlight sessions that highlight the opportunity for algae to impact particular market and R&D segments.
ZIVO Bioscience, Inc., is delighted to announce that some of its key management team will be speakers at this segment on Thursday, August 27, 2020 from between 10:00 am to 12:00 pm CT, discussing the Algae in Animal Feeds and the Effective Market Entry
Here is a short description of their speaking segment:
Andrew Dahl, CEO, ZIVO Bioscience
Commercializing Microalgae for Animal Health & Nutrition Applications Feed ingredients for poultry, swine and cattle offer ample opportunities, but the value proposition must be realistic.
Authors: Andrew A. Dahl ZIVO Bioscience, Inc.
Abstract: US poultry producers purchase 34 million tons of poultry feed each year. Every ton of feed contains varying amounts of medications, minerals, vaccines, chemicals and specialty ingredients such as phytogenic, prebiotic or probiotic products, in addition to the corn and soy that make up the bulk of the feed mix. Competition for that 20 to 500 grams of specialty product inclusion is fierce, the margins are thin and the capital costs are daunting. And, the producers aren’t shy about pushing down the price on these specialty ingredients if they don’t deliver on their promises. But, there are pressures on the producers, as well. Consumers are demanding antibiotic-free, ionophore-free poultry products, and many producers have opted to convert to No Antibiotics Ever (NAE) production. The result is lower productivity, lower margins and compromises in quality, which has producers searching for natural products to improve animal health and feed conversion rates. The ZIVO presentation centers on understanding the producer value proposition and how to marshal the necessary capital resources, technology and production strategies to deliver a viable product and a return on investment.
William Pfund, VP R&D, ZIVO Bioscience
Scientific Support of Microalgae Commercialization: There's No Such Thing as Too Much Data
Authors: William P. Pfund, ZIVO Bioscience, Inc.
Abstract: As the evolving regulatory landscape and demands of end consumers push the poultry industry to eliminate the use of antibiotics and other chemical growth promoters, producers have looked to natural alternatives to fill the void. And while the number of phytogenic alternatives offered to producers seems to be ever-growing, a very large percentage of putative alternatives have not performed as promised, resulting in an air of cynicism surrounding any new, naturally derived alternative. This tendency towards skepticism has accentuated the need for a robust and credible data package accompanying any new product feed ingredient aimed at improving farm productivity. Moreover, from the poultry producers’ point of view, efficacy data from a few proof-of-concept trials is not even close to being sufficient to justify an initial product trial. Instead, producers are demanding data from extensive field trials as well as data clearly defining the product’s mechanism of action. Beyond satisfying marketing needs, extensive product characterization is required to support product registration and compliance, and to support production process development.
This presentation will provide an overview of what is required to establish an integrated scientific strategy to support various aspects of commercializing a novel algal-based feed ingredient including credible efficacy testing, defining the mechanism of action, supporting compliance activities, and internal product development and support activities. Examples and lessons learned from ZIVO’s efforts to commercialize an animal feed ingredient based on the company’s proprietary strain of fresh water microalgae will be provided.
